Cited by 441Tryptophan and brain disordersAdipokines, Inflammation, and Metabolic DiseasesRegulation of Appetite and Obesity

The DOI matches its Crossref record; 167 of the 173 references it cites were found in a registry or an index; 1 of the 136 sources its claims cite were checked for support.

The menace of obesity to depression and anxiety prevalence

Open access

Abstract

The incidence of depression and anxiety is amplified by obesity. Mounting evidence reveals that the psychiatric consequences of obesity stem from poor diet, inactivity, and visceral adipose accumulation. Resulting metabolic and vascular dysfunction, including inflammation, insulin and leptin resistance, and hypertension, have emerged as key risks to depression and anxiety development. Recent research advancements are exposing the important contribution of these different corollaries of obesity and their impact on neuroimmune status and the neural circuits controlling mood and emotional states. Along these lines, this review connects the clinical manifestations of depression and anxiety in obesity to our current understanding of the origins and biology of immunometabolic threats to central nervous system function and behavior.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This review argues that obesity raises the risk of depression and anxiety mainly through immunometabolic and neuroinflammatory consequences of poor diet, inactivity, and visceral adiposity, rather than body weight alone. It synthesizes human epidemiological and rodent mechanistic evidence linking adipose and gut inflammation, neuroinflammation, neuroplastic and monoamine changes, and endocrine dysfunction to mood disorders.

Key findings

  • Obesity increases depression risk: a meta-analytic overview cited by the review reports that obese adults self-reporting symptoms have 23–36% increased odds of developing depressed mood versus nonobese controls, while clinically diagnosed MDD is elevated by 14–34%; obese adolescents have a 40% increased risk of being depressed.
  • Obesity also increases anxiety risk: the review states obesity heightens the odds of an anxiety disorder or anxiety symptoms by 30% and 40%, respectively, with a stronger relationship for severe obesity (BMI ≥ 35); diabetes is associated with a 48% greater likelihood of anxiety symptoms and a 20% higher risk of developing an anxiety disorder.
  • Sex and metabolic status matter: depression and anxiety disorder diagnoses are approximately double for obese women compared with obese men, and metabolically healthy obese individuals show either no increased risk or a modest elevated risk of depression diagnosis versus nonobese controls.
  • Proposed mechanisms include saturated fat and sugar intake, visceral adipose expansion, gut dysbiosis, peripheral inflammation (e.g., CRP, IL-6, TNFα), insulin and leptin resistance, HPA dysregulation, neuroinflammation, altered corticolimbic circuits, monoamine imbalances, and reduced hippocampal neurogenesis.

Methods

  • Narrative review; no primary data collection, systematic search, or meta-analysis is reported.
  • Synthesizes clinical and epidemiological observations with rodent models of diet-induced obesity, high-fat/high-sugar feeding, and depressive- or anxiety-like behaviors.
  • Main analysis is qualitative integration of evidence across immunometabolic, neuroinflammatory, neural circuit, monoamine, and endocrine domains.

Limitations

  • Stated: the causal relationship of diet-induced obesity to depression and anxiety in human studies is indirect; the literature linking inflammation to anxiety is much sparser; microbiota alterations across studies are conflicting and mechanisms remain unclear; the precise contribution of HPA activity and insulin’s role in mood circuits remain to be established; and it remains poorly understood to what degree particular changes are causal or a consequence of mood and metabolic changes.
  • Stated: human leptin studies are limited, and evidence for depression and obesity comorbidity is described as limited in the concluding remarks.
  • Evident: as a narrative review, it does not systematically quantify or appraise the evidence, and much mechanistic support comes from rodent models, so human causality and effect sizes are not established by this paper itself.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.tem.2021.10.005

Cites

167 of 167 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

91 Not checked yet · 21 Own interpretation · 1 Partly supported · 1 No basis given · accuracy not yet measured

Verify all 135 references — free account

Show all 73 claims

  • It may state two separate claims as one. 38
  • Probably not a substantial claim. 4
41 of 41
  • The paper relies on this without support.

    Findings from rodent models of obesity and depressive- and anxiety-like behaviors translate to human depression and anxiety.

    “Clinical observations combined with rodent models of obesity exhibiting depressive-and anxiety-like behaviors are proving valuable for uncovering the immunometabolic and neural mechanisms”
    “To this end, rodent research has revealed that prolonged high-fat diet (HFD) elicits metabolic dysfunction and increases anxiety-and depressive-like behaviors [28][29][30][31][32][33][34][35][36], heightens stress and hypothalamic-pituitary-adrenal (HPA) responses [37,38], and triggers neurobehavioral deficits associated with blunted mesolimbic dopamine function [39][40][41].”
  • The paper relies on this without support.

    Gut microbiota alterations observed in diet-induced obese mice translate to human obesity-related mood dysfunction.

    “Notably, both the obese phenotype [73] and anxiodepressive behaviors [74] are transmissible by transplanting gut microbiota of DIO to normal-weight, germ-free mice.”
  • The paper relies on this without support.

    Findings from rodent models of diet-induced obesity and depressive/anxiety-like behaviors can be generalized to human obesity-induced depression and anxiety.

    “The collective findings in rodents, along with reports of structural and functional changes in obese humans, support the clinical relevance of this mechanism.”
  • The paper relies on this without support.

    Obesity causally contributes to the development of depression and anxiety, rather than being solely a consequence or correlated.

    “New research developments uncovering the metabolic and neurobiological mechanisms by which obesity heightens the risk of depression and anxiety will prove valuable for evaluating new treatment strategies”
4 of 4

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 173 references

Cited by

Sorted by citations

See all 441

Metadata

Authors
Fulton, S., Décarie-Spain, L., Fioramonti, X., Guiard, B., & Nakajima, S.
Affiliations
  • Centre Hospitalier de l’Université de Montréal (CA)
  • Université de Bordeaux (FR)
  • Centre National de la Recherche Scientifique (FR)
Corresponding author
Fulton, Stephanie
Venue
Trends in Endocrinology & Metabolism
Publisher
Elsevier BV
Published
2022-01
Volume
33
Issue
1
Pages
18-35
ISSN
1043-2760 (ISSN-L)
OpenAlex
W3213132689
Cited by
441
References
173
Citations by year
2026: 75 · 2025: 135 · 2024: 100 · 2023: 92 · 2022: 39
FWCI
5.46
Type
journal article
Language
en
Open access
Locations
  • Trends in Endocrinology and Metabolism (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by-nc-nd)
  • Oskar-Bordeaux (Universite de Bordeaux) (submittedVersion, cc-by-nc-nd)
Funders
  • Fonds de Recherche du Québec - Santé
  • Japan Society for the Promotion of Science
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
obesity, depression, anxiety, neuroinflammation, insulin resistance, leptin resistance, visceral adipose tissue, hypertension, metabolic dysfunction, neuroimmune dysfunction, mood regulation
MeSH terms
Anxiety, Depression, Humans, Inflammation, Obesity, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review